APA (7th ed.) Citation

Hannich, J. T., Loizides‐Mangold, U., Sinturel, F., Harayama, T., Vandereycken, B., Saini, C., . . . Dibner, C. (2021). Ether lipids, sphingolipids and toxic 1‐deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta Physiologica, 232(1), e13610-n/a. https://doi.org/10.1111/apha.13610

Chicago Style (17th ed.) Citation

Hannich, J. Thomas, et al. "Ether Lipids, Sphingolipids and Toxic 1‐deoxyceramides as Hallmarks for Lean and Obese Type 2 Diabetic Patients." Acta Physiologica 232, no. 1 (2021): e13610-n/a. https://doi.org/10.1111/apha.13610.

MLA (9th ed.) Citation

Hannich, J. Thomas, et al. "Ether Lipids, Sphingolipids and Toxic 1‐deoxyceramides as Hallmarks for Lean and Obese Type 2 Diabetic Patients." Acta Physiologica, vol. 232, no. 1, 2021, pp. e13610-n/a, https://doi.org/10.1111/apha.13610.